168 related articles for article (PubMed ID: 31150495)
1. Pharmacokinetic parameters and mechanism of action of an efficient anti-Aβ single chain antibody fragment.
Esquerda-Canals G; Martí-Clúa J; Villegas S
PLoS One; 2019; 14(5):e0217793. PubMed ID: 31150495
[TBL] [Abstract][Full Text] [Related]
2. Aβ-oligomer uptake and the resulting inflammatory response in adult human astrocytes are precluded by an anti-Aβ single chain variable fragment in combination with an apoE mimetic peptide.
Montoliu-Gaya L; Mulder SD; Herrebout MAC; Baayen JC; Villegas S; Veerhuis R
Mol Cell Neurosci; 2018 Jun; 89():49-59. PubMed ID: 29625180
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of apoE and apoJ mimetic peptides on the action of an anti-Aβ scFv in 3xTg-AD mice.
Montoliu-Gaya L; Güell-Bosch J; Esquerda-Canals G; Roda AR; Serra-Mir G; Lope-Piedrafita S; Sánchez-Quesada JL; Villegas S
Biochem Pharmacol; 2018 Sep; 155():380-392. PubMed ID: 30026023
[TBL] [Abstract][Full Text] [Related]
4. Progression of Alzheimer's disease and effect of scFv-h3D6 immunotherapy in the 3xTg-AD mouse model: An in vivo longitudinal study using Magnetic Resonance Imaging and Spectroscopy.
Güell-Bosch J; Lope-Piedrafita S; Esquerda-Canals G; Montoliu-Gaya L; Villegas S
NMR Biomed; 2020 May; 33(5):e4263. PubMed ID: 32067292
[TBL] [Abstract][Full Text] [Related]
5. Effects of an Aβ-antibody fragment on Aβ aggregation and astrocytic uptake are modulated by apolipoprotein E and J mimetic peptides.
Montoliu-Gaya L; Mulder SD; Veerhuis R; Villegas S
PLoS One; 2017; 12(11):e0188191. PubMed ID: 29155887
[TBL] [Abstract][Full Text] [Related]
6. Towards the improvement in stability of an anti-Aβ single-chain variable fragment, scFv-h3D6, as a way to enhance its therapeutic potential.
Montoliu-Gaya L; Murciano-Calles J; Martinez JC; Villegas S
Amyloid; 2017 Sep; 24(3):167-175. PubMed ID: 28699800
[TBL] [Abstract][Full Text] [Related]
7. Treatment with scFv-h3D6 Prevented Neuronal Loss and Improved Spatial Memory in Young 3xTg-AD Mice by Reducing the Intracellular Amyloid-β Burden.
Esquerda-Canals G; Roda AR; Martí-Clúa J; Montoliu-Gaya L; Rivera-Hernández G; Villegas S
J Alzheimers Dis; 2019; 70(4):1069-1091. PubMed ID: 31306135
[TBL] [Abstract][Full Text] [Related]
8. An anti-Aβ (amyloid β) single-chain variable fragment prevents amyloid fibril formation and cytotoxicity by withdrawing Aβ oligomers from the amyloid pathway.
Marín-Argany M; Rivera-Hernández G; Martí J; Villegas S
Biochem J; 2011 Jul; 437(1):25-34. PubMed ID: 21501114
[TBL] [Abstract][Full Text] [Related]
9. Loss of deep cerebellar nuclei neurons in the 3xTg-AD mice and protection by an anti-amyloid β antibody fragment.
Esquerda-Canals G; Marti J; Rivera-Hernández G; Giménez-Llort L; Villegas S
MAbs; 2013; 5(5):660-4. PubMed ID: 23884149
[TBL] [Abstract][Full Text] [Related]
10. Early intervention in the 3xTg-AD mice with an amyloid β-antibody fragment ameliorates first hallmarks of Alzheimer disease.
Giménez-Llort L; Rivera-Hernández G; Marin-Argany M; Sánchez-Quesada JL; Villegas S
MAbs; 2013; 5(5):665-77. PubMed ID: 23884018
[TBL] [Abstract][Full Text] [Related]
11. Improved Brain Expression of Anti-Amyloid β scFv by Complexation of mRNA Including a Secretion Sequence with PEG-based Block Catiomer.
Perche F; Uchida S; Akiba H; Lin CY; Ikegami M; Dirisala A; Nakashima T; Itaka K; Tsumoto K; Kataoka K
Curr Alzheimer Res; 2017; 14(3):295-302. PubMed ID: 27829339
[TBL] [Abstract][Full Text] [Related]
12. Elongation of the C-terminal domain of an anti-amyloid β single-chain variable fragment increases its thermodynamic stability and decreases its aggregation tendency.
Rivera-Hernández G; Marin-Argany M; Blasco-Moreno B; Bonet J; Oliva B; Villegas S
MAbs; 2013; 5(5):678-89. PubMed ID: 23924802
[TBL] [Abstract][Full Text] [Related]
13. Both Amyloid-β Peptide and Tau Protein Are Affected by an Anti-Amyloid-β Antibody Fragment in Elderly 3xTg-AD Mice.
Roda AR; Montoliu-Gaya L; Serra-Mir G; Villegas S
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32927795
[TBL] [Abstract][Full Text] [Related]
14. Chronic intranasal treatment with an anti-Aβ(30-42) scFv antibody ameliorates amyloid pathology in a transgenic mouse model of Alzheimer's disease.
Cattepoel S; Hanenberg M; Kulic L; Nitsch RM
PLoS One; 2011 Apr; 6(4):e18296. PubMed ID: 21483675
[TBL] [Abstract][Full Text] [Related]
15. A Novel scFv Anti-Aβ Antibody Reduces Pathological Impairments in APP/PS1 Transgenic Mice via Modulation of Inflammatory Cytokines and Aβ-related Enzymes.
Hu M; Zhang J; Yang J; Cao Y; Qi J
J Mol Neurosci; 2018 Sep; 66(1):1-9. PubMed ID: 30062438
[TBL] [Abstract][Full Text] [Related]
16. Amelioration of amyloid load by anti-Abeta single-chain antibody in Alzheimer mouse model.
Fukuchi K; Accavitti-Loper MA; Kim HD; Tahara K; Cao Y; Lewis TL; Caughey RC; Kim H; Lalonde R
Biochem Biophys Res Commun; 2006 May; 344(1):79-86. PubMed ID: 16630540
[TBL] [Abstract][Full Text] [Related]
17. Production of an anti-Aβ antibody fragment in Pichia pastoris and in vitro and in vivo validation of its therapeutic effect.
Montoliu-Gaya L; Esquerda-Canals G; Bronsoms S; Villegas S
PLoS One; 2017; 12(8):e0181480. PubMed ID: 28771492
[TBL] [Abstract][Full Text] [Related]
18. Preparation and in vitro activity of single chain antibodies against Alzheimer's disease.
Fu L; Zhang Y; Zhang X; Tian W; Zhang W; Jia Y; Zhang L
Immunol Lett; 2020 Nov; 227():1-7. PubMed ID: 32781005
[TBL] [Abstract][Full Text] [Related]
19. A conformation-specific antibody against oligomeric β-amyloid restores neuronal integrity in a mouse model of Alzheimer's disease.
He P; Schulz P; Sierks MR
J Biol Chem; 2021; 296():100241. PubMed ID: 33376140
[TBL] [Abstract][Full Text] [Related]
20. Anti-Aβ single-chain variable fragment antibodies exert synergistic neuroprotective activities in Drosophila models of Alzheimer's disease.
Fernandez-Funez P; Zhang Y; Sanchez-Garcia J; de Mena L; Khare S; Golde TE; Levites Y; Rincon-Limas DE
Hum Mol Genet; 2015 Nov; 24(21):6093-105. PubMed ID: 26253732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
